170 related articles for article (PubMed ID: 9793597)
1. Glimepiride: role of a new sulfonylurea in the treatment of type 2 diabetes mellitus.
Campbell RK
Ann Pharmacother; 1998 Oct; 32(10):1044-52. PubMed ID: 9793597
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety profile of glimepiride in Mexican American Patients with type 2 diabetes mellitus: a randomized, placebo-controlled study.
Luis Bautista J; Bugos C; Dirnberger G; Atherton T
Clin Ther; 2003 Jan; 25(1):194-209. PubMed ID: 12637120
[TBL] [Abstract][Full Text] [Related]
3. Glimepiride in type 2 diabetes mellitus: a review of the worldwide therapeutic experience.
Massi-Benedetti M
Clin Ther; 2003 Mar; 25(3):799-816. PubMed ID: 12852703
[TBL] [Abstract][Full Text] [Related]
4. [Glimepiride--an oral antidiabetic agent].
Becić F; Kapić E; Becić E
Med Arh; 2003; 57(2):125-7. PubMed ID: 12822388
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.
Hermansen K; Kipnes M; Luo E; Fanurik D; Khatami H; Stein P;
Diabetes Obes Metab; 2007 Sep; 9(5):733-45. PubMed ID: 17593236
[TBL] [Abstract][Full Text] [Related]
6. Short-term comparison of once- versus twice-daily administration of glimepiride in patients with non-insulin-dependent diabetes mellitus.
Sonnenberg GE; Garg DC; Weidler DJ; Dixon RM; Jaber LA; Bowen AJ; DeChemey GS; Mullican WS; Stonesifer LD
Ann Pharmacother; 1997 Jun; 31(6):671-6. PubMed ID: 9184703
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.
Johnson JL; Wolf SL; Kabadi UM
Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835
[TBL] [Abstract][Full Text] [Related]
8. Glimepiride. A review of its use in the management of type 2 diabetes mellitus.
Langtry HD; Balfour JA
Drugs; 1998 Apr; 55(4):563-84. PubMed ID: 9561345
[TBL] [Abstract][Full Text] [Related]
9. [Sulfonylurea drug--a new sulfonylurea drug for type 2 diabetes].
Toyota T
Nihon Rinsho; 1999 Mar; 57(3):695-701. PubMed ID: 10199156
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic basis for the safety of glimepiride in risk groups of NIDDM patients.
Rosenkranz B
Horm Metab Res; 1996 Sep; 28(9):434-9. PubMed ID: 8911979
[TBL] [Abstract][Full Text] [Related]
11. Practical considerations and guidelines for dosing sulfonylureas as monotherapy or combination therapy.
Bell DS
Clin Ther; 2004 Nov; 26(11):1714-27. PubMed ID: 15639686
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of glimepiride in type 2 diabetic patients: compared effects of once- versus twice-daily dosing.
Matsuki M; Matsuda M; Kohara K; Shimoda M; Kanda Y; Tawaramoto K; Shigetoh M; Kawasaki F; Kotani K; Kaku K
Endocr J; 2007 Aug; 54(4):571-6. PubMed ID: 17603225
[TBL] [Abstract][Full Text] [Related]
13. A placebo-controlled, randomized study of glimepiride in patients with type 2 diabetes mellitus for whom diet therapy is unsuccessful.
Schade DS; Jovanovic L; Schneider J
J Clin Pharmacol; 1998 Jul; 38(7):636-41. PubMed ID: 9702849
[TBL] [Abstract][Full Text] [Related]
14. [Glimepiride in daily practice].
Jasik M
Przegl Lek; 2003; 60(6):409-12. PubMed ID: 14974179
[TBL] [Abstract][Full Text] [Related]
15. Clinical review of glimepiride.
McCall AL
Expert Opin Pharmacother; 2001 Apr; 2(4):699-713. PubMed ID: 11336617
[TBL] [Abstract][Full Text] [Related]
16. Sulfonylurea treatment of type 2 diabetes mellitus: focus on glimepiride.
Korytkowski MT
Pharmacotherapy; 2004 May; 24(5):606-20. PubMed ID: 15162895
[TBL] [Abstract][Full Text] [Related]
17. Clinical profile of the novel sulphonylurea glimepiride.
Rosskamp R; Wernicke-Panten K; Draeger E
Diabetes Res Clin Pract; 1996 Jul; 31 Suppl():S33-42. PubMed ID: 8864639
[TBL] [Abstract][Full Text] [Related]
18. The newly developed sulfonylurea glimepiride: a new ingredient, an old recipe.
Veneman TF; Tack CJ; van Haeften TW
Neth J Med; 1998 May; 52(5):179-86. PubMed ID: 9652156
[TBL] [Abstract][Full Text] [Related]
19. Results of a randomized, double-blind, placebo-controlled study administering glimepiride to patients with type 2 diabetes mellitus inadequately controlled with rosiglitazone monotherapy.
McCluskey D; Touger MS; Melis R; Schleusener DS; McCluskey D
Clin Ther; 2004 Nov; 26(11):1783-90. PubMed ID: 15639690
[TBL] [Abstract][Full Text] [Related]
20. Pioglitazone/glimepiride (Duetact) for diabetes.
Med Lett Drugs Ther; 2007 Jan; 49(1253):9-11. PubMed ID: 17261966
[No Abstract] [Full Text] [Related]
[Next] [New Search]
